Close Menu

NEW YORK – MedGenome announced on Wednesday that it has received an investment of $55 million.

The genetic diagnostics, research, and data company — which focuses on expanding access to genetic testing for populations in South Asia and other emerging markets — said it will use the funding to expand its clinical genomic testing efforts into additional towns and cities in India, and to accelerate its drug discovery programs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.